IR News

Sumitomo Dainippon Pharma Co., Ltd. (Head Office: Osaka, Japan; Representative Director, President and CEO: Hiroshi Nomura) today announced the following organizational realignment and changes in Executive Officers and other key positions, effective April 1, 2020:

I. Organizational Realignment (effective April 1, 2020)

Corporate Departments

Global Oncology Office is dissolved.

* The functions of business strategy planning and building frameworks for research and development will be transferred to the Global Strategy & Planning function, which will be placed under the Global Head of Oncology, while the functions of formulation/promotion of project strategies and management of research, development, and medical affairs will be transferred to the Oncology Clinical Development Unit.

Corporate Regulatory Compliance & Quality Assurance (Division)

Regulatory Compliance & Quality Assurance Management and Clinical & Research Quality Assurance are integrated and renamed to Regulatory Compliance & Quality Assurance Management.^*
* The English name remains unchanged from that of former entities.

Sales & Marketing (Division)

1. Product Management & Promotion Planning is renamed to Product Marketing.
2. CNS Product Management & Promotion Planning is renamed to CNS Product Marketing.

Sumitomo Dainippon Pharma America, Inc. (a holding company in the U.S.)

In order to further enhance the efficiency of North America business, Sumitomo Dainippon Pharma America, Inc. changes its form of incorporation from a holding company to a company that encompasses some of the functions of our North American subsidiaries (Sunovion Pharmaceuticals Inc., Boston Biomedical, Inc., and Tolero Pharmaceuticals, Inc.), including legal affairs, intellectual property, internal audit, compliance, and financial operations.

II. Changes in Executive Officers

(1) Retiring Director (effective March 31, 2020)

Nobuhiko Tamura (currently Member, Board of Directors, Senior Executive Officer)

(2) Promotions (effective April 1, 2020)

Senior Executive Officer
Shigeyuki Nishinaka (currently Executive Officer)

(3) New Executive Officers (effective April 1, 2020)

Koichi Kozuki (currently Executive Director, Drug Development Division)
Isao Shimizu (currently Senior Director, External Innovation)
Yumi Sato (currently Senior Director, Global Corporate Strategy)

(4) Retiring Executive Officers (effective March 31, 2020)

Nobuhiko Tamura (currently Member, Board of Directors, Senior Executive Officer)
Kazuo Koshiya (currently Senior Executive Officer)
Kazuhiro Takada (currently Executive Officer)

* Nobuhiko Tamura will assume the position of Representative Director, President, Nihon Medi-Physics Co., Ltd., effective April 1, 2020.

(5) Changes in the positions assumed by Executive Officers (effective April 1, 2020)

Position as of April 1, 2020	Current position	Name
Member, Board of Directors, Senior Executive Officer Chief Scientific Officer Regenerative & Cellular Medicine Office; Regenerative & Cellular Medicine Kobe Center; Regenerative & Cellular Medicine Manufacturing Plant; Drug Research Division Senior Executive Research Director, Drug Research Division	Member, Board of Directors, Senior Executive Officer Regenerative & Cellular Medicine Office; Regenerative & Cellular Medicine Kobe Center; Regenerative & Cellular Medicine Manufacturing Plant; Drug Research Division Senior Executive Research Director, Drug Research Division Chief Research Officer	Toru Kimura
Senior Executive Officer Regulatory Affairs; Medical Information, Medical Affairs; Corporate Regulatory Compliance & Quality Assurance Division; Technology Research & Development Division; Manufacturing Division Executive Director, Corporate Regulatory Compliance & Quality Assurance Division Deputy Head of Japan Business Unit	Senior Executive Officer Technology Research & Development Division; Manufacturing Division Executive Director, Manufacturing Division Deputy Head of Japan Business Unit	Yoshiharu Ikeda
Senior Executive Officer Global Data Design Office; External Affairs; Legal Affairs; Intellectual Property; Corporate Secretariat; IT Management & Digital Transformation; Frontier Business Office	Senior Executive Officer Global Corporate Strategy; Global Data Design Office; IT Management & Digital Transformation; Frontier Business Office	Hiroyuki Baba
Senior Executive Officer Global Corporate Strategy; Global Business Development; International Business Management	Executive Officer Global Business Development; International Business Management Senior Director, Global Business Development	Shigeyuki Nishinaka
Executive Officer Corporate Governance; Corporate Communications; Human Resources	Executive Officer Corporate Communications; Human Resources	Atsuko Higuchi
Executive Officer Chair and CEO, Sumitomo Dainippon Pharma America, Inc.	Executive Officer Executive Vice President and Chief Corporate Strategy Officer, Sunovion Pharmaceuticals Inc.	Shinichiro Katayanagi
Executive Officer Drug Development Division Executive Director, Drug Development Division Deputy Head of Japan Business Unit	Executive Director, Drug Development Division	Koichi Kozuki
Executive Officer Executive Research Director, Drug Research Division	Senior Director, External Innovation	Isao Shimizu
Executive Officer Executive Vice President and Chief Corporate Strategy Officer, Sunovion Pharmaceuticals Inc.	Senior Director, Global Corporate Strategy	Yumi Sato
Executive Officer CEO, Boston Biomedical, Inc. Global Head of Oncology	Executive Officer CEO, Boston Biomedical, Inc.	Patricia S. Andrews

III. Changes in Personnel (effective April 1, 2020)

Corporate Departments

Position as of April 1, 2020	Current position	Name
Senior Director, Global Corporate Strategy	Senior Director, Global Oncology Office	Tsutomu Nakagawa
Senior Director, Global Business Development	Tolero Pharmaceuticals, Inc. Senior Oncology Business Officer	Katsumi Tanaka
Senior Director, Corporate Secretariat	Senior Director, Pharmacovigilance	Koichi Kino
Senior Director, Human Resources	Senior Director, Kyushu Branch	Koji Yamazaki
Senior Director, Regenerative & Cellular Medicine Office	External Affairs Senior Director, Corporate Secretariat	Tomokazu Nagano
Senior Director, Regenerative & Cellular Medicine Kobe Center	Senior Research Fellow, iPS Cell-Based Drug Discovery	Atsushi Ikeda
Senior Director, DSP Cancer Institute	Senior Director, Research Planning & Coordination	Setsuko Yamamoto
Boston Biomedical, Inc. Senior Oncology Strategy Officer	Boston Biomedical, Inc. Corporate Strategy & Planning Officer for Boston Biomedical, Inc.	Masashi Murata

Corporate Regulatory Compliance & Quality Assurance (Division)

Position as of April 1, 2020	Current position	Name
Senior Director, Regulatory Compliance & Quality Assurance Management	Sunovion Pharmaceuticals Inc.	Teruya Murata
Senior Director, Pharmacovigilance	Senior Director, Clinical & Research Quality Assurance	Michie Kuroda

Drug Research (Division)

Position as of April 1, 2020	Current position	Name
Senior Director, Research Planning & Coordination	Senior Director, Regenerative & Cellular Medicine Office Director, Business Planning Group, Regenerative & Cellular Medicine Office	Atsushi Tsuchida
Senior Director, External Innovation	Director, Group Ⅲ, Platform Technology Research Unit Research Planning & Coordination Group, Research Planning & Coordination	Yukiko Mine

Technology Research & Development (Division)

Position as of April 1, 2020	Current position	Name
Executive Director, Technology Research & Development Division	Deputy Executive Director, Manufacturing Division Senior Director, Suzuka Plant	Kenji Ueno

Sales & Marketing (Division)

Position as of April 1, 2020	Current position	Name
Senior Director, Product Marketing	Senior Director, Product Management & Promotion Planning	Masayuki Mukai
Senior Director, CNS Product Marketing	Senior Director, CNS Product Management & Promotion Planning	Tsuneharu Inoue
Senior Director, Personnel Development	Director, Career Development Group, Personnel Development	Satsuki Otani
Senior Director, Sapporo Branch	Senior Director, Koshinetsu Branch	Katsuhiko Nishida
Senior Director, Tohoku Branch	Senior Director, Sapporo Branch	Manabu Tatsukawa
Senior Director, Kita-Kanto Branch	Boston Biomedical, Inc.	Takafumi Shimizu
Senior Director, Koshinetsu Branch	Director, Managerial Administration Group, Sales & Marketing Management Director, Planning & Marketing Group, Sales & Marketing Management	Yasushi Kimura
Senior Director, Chiba Branch	Senior Director, Kobe Branch	Noboru Hirata
Senior Director, Yokohama Branch	Senior Director, Shikoku Branch	Takafumi Ishibashi
Senior Director, Tokai Branch	Senior Director, Kita-Kanto Branch	Hiroshi Takaoka
Senior Director, Keiji-Hokuriku Branch	Senior Director, Personnel Development	Junya Kanto
Senior Director, Osaka Branch	Senior Director, Human Resources	Ichiro Takahashi
Senior Director, Kobe Branch	Director, Labor Relations Group, Human Resources	Tomoko Nakagawa
Senior Director, Chugoku Branch	Senior Director, Yokohama Branch	Yasutoshi Araki
Senior Director, Shikoku Branch	Director, Product GroupⅠ, Product Management & Promotion Planning	Yoshihiro Ariyama
Senior Director, Kyushu Branch	Senior Director, Chugoku Branch	Hidekatsu Kuroda

Manufacturing (Division)

Position as of April 1, 2020	Current position	Name
Executive Director, Manufacturing Division Deputy Head of Japan Business Unit	Executive Director, Technology Research & Development Division	Kazuhiko Takahashi
Senior Director, Suzuka Plant	Senior Manufacturing Officer	Hiroyuki Nishii
Deputy Senior Director, Administration, Suzuka Plant	Deputy Senior Director, Manufacturing Department Ⅱ, Suzuka Plant	Kazuyuki Fujihara
Deputy Senior Director, Manufacturing Department Ⅱ, Suzuka Plant	Director, Formulation Research GroupⅠ, Formulation Research & Development Laboratories	Toru Fukushima